Bank of America’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-95
Closed -$27 7160
2025
Q4
$27 Hold
95
﹤0.01% 7077
2025
Q3
$28 Hold
95
﹤0.01% 8129
2025
Q2
$22 Sell
95
-5
-5% -$1 ﹤0.01% 8236
2025
Q1
$14 Buy
+100
New +$18 ﹤0.01% 8187

Other funds holding TDACW

Bank of America's TDACW Position: Q1 2026 in Review

Bank of America sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q1 2026, closing a stake of 95 shares — an estimated $27 sold.

Bank of America first reported a position in TDACW in Q1 2025 and held it in 4 quarters. The position peaked at $28 in Q3 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Bank of America reported no remaining Translational Development Acquisition Corp Warrants position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 95 Translational Development Acquisition Corp Warrants shares in Q1 2026, an estimated $27.
  • Bank of America first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and held it in 4 quarters.
  • Bank of America's Translational Development Acquisition Corp Warrants position peaked at $28 in Q3 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.